CareDx Inc. (CDNA) Insider Trading

Last 12 months

Insiders sold $13.3M and bought nothing on the open market.

76% of the selling was scheduled in advance under 10b5-1 plans. Director Michael Goldberg sold $2.1M on Aug 4, 23% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2021.

Net open-market

−$13.3M

0 buys · 19 sales

Under a 10b5-1 plan

76%

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

Nov 2021

Nov 24, 2021

Get an email when CDNA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 5	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan 2 parts	2,688	$46.26 average	$124k	2.5%	Form 4
Aug 5	George Bickerstaff Director	SoldNo plan	20,000	$46.29	$926k	13%	Form 4
Aug 4	Michael Goldberg Director	SoldNo plan	44,700	$47.06	$2.1M	23%	Form 4
Aug 4	Christine Cournoyer Director	Sold10b5-1 plan	16,000	$46.94	$751k	27%	Form 4
Jul 16	Hannah Valantine Director	Sold10b5-1 plan 2 parts	28,779	$36.14 average	$1.04M	44%	Form 4
Jul 16	John Walter Hanna Jr President and CEO	Sold10b5-1 plan 2 parts	118,000	$37.78 average	$4.46M	15%	Form 4
Jun 26 – 29	John Walter Hanna Jr President and CEO	Sold10b5-1 plan 2 parts	40,000	$29.24 average	$1.17M	5.7%	Form 4
Jun 15	John Walter Hanna Jr President and CEO	Sold10b5-1 plan	17,683	$24.03	$425k	2.7%	Form 4
Jun 15	Hannah Valantine Director	Sold10b5-1 plan	12,103	$23.11	$280k	25%	Form 4
Jun 11	John Walter Hanna Jr President and CEO	Sold10b5-1 plan	21,998	$24.02	$528k	3.3%	Form 4
Jun 4	John Walter Hanna Jr President and CEO	Sold10b5-1 plan	4,835	$24.00	$116k	0.7%	Form 4
May 14 – 15	Arthur A Torres Director	SoldNo plan 2 parts	10,570	$20.31 average	$215k	21%	Form 4
May 5	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	2,688	$20.68	$56k	2.3%	Form 4
Apr 16	John Walter Hanna Jr President and CEO	Sold10b5-1 plan	10,282	$21.12	$217k	1.5%	Form 4
Feb 3	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	4,441	$20.56	$91k	3.4%	Form 4
Jan 21 – 22	John Walter Hanna Jr President and CEO	Sold10b5-1 plan 2 parts	19,480	$21.16 average	$412k	3.2%	Form 4
Jan 15	John Walter Hanna Jr President and CEO	Sold10b5-1 plan	10,156	$21.05	$214k	1.6%	Form 4
Dec 4, 2025	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan 2 parts	7,293	$19.17 average	$140k	6.9%	Form 4
Nov 7, 2025	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	2,688	$15.52	$42k	2.5%	Form 4
Aug 5, 2025	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	2,688	$12.79	$34k	2.3%	Form 4
Jul 7, 2025	Peter Maag Director	Sold10b5-1 plan	10,000	$18.58	$186k	3.1%	Form 4
Jun 18, 2025	Hannah Valantine Director	Sold10b5-1 plan	10,570	$19.16	$203k	21%	Form 4
Jun 17, 2025	Peter Maag Director	Sold10b5-1 plan	10,000	$19.24	$192k	3.0%	Form 4
Jun 11, 2025	William A Hagstrom Director	SoldNo plan	19,391	$19.90	$386k	26%	Form 4
May 28, 2025	William A Hagstrom Director	SoldNo plan	30,000	$17.45	$524k	36%	Form 4
May 12, 2025	Christine Cournoyer Director	SoldNo plan	29,136	$15.96	$465k	44%	Form 4
May 6, 2025	Christine Cournoyer Director	SoldNo plan	16,700	$14.13	$236k	31%	Form 4
May 5, 2025	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	2,688	$14.70	$40k	2.2%	Form 4
Apr 30, 2025	Peter Maag Director	Sold10b5-1 plan	13,281	$17.23	$229k	4.0%	Form 4
Apr 7, 2025	Jeffrey Adam Novack Secretary and General Counsel	SoldNo plan	924	$17.72	$16k	0.7%	Form 4
Apr 7, 2025	Abhishek Jain Chief Financial Officer	SoldNo plan	265	$17.72	$5k	<0.1%	Form 4
Mar 10, 2025	George Bickerstaff Director	SoldNo plan	20,000	$18.36	$367k	16%	Form 4
Feb 4, 2025	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	3,512	$23.30	$82k	3.2%	Form 4
Dec 4, 2024	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan	1,917	$26.00	$50k	1.7%	Form 4
Nov 26, 2024	Peter Maag Director	Sold10b5-1 plan	5,000	$25.00	$125k	1.5%	Form 4
Nov 18, 2024 – Nov 25, 2024	Jeffrey Adam Novack Secretary and General Counsel	Sold10b5-1 plan 5 parts	6,757	$22.17 average	$150k	5.7%	Form 4

Aug 510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 2,688 at avg $46.26
$124k
2.5% of stake
Aug 5No plan
George Bickerstaff
Director · sold 20,000 at $46.29
$926k
13% of stake
Aug 4No plan
Michael Goldberg
Director · sold 44,700 at $47.06
$2.1M
23% of stake
Aug 410b5-1 plan
Christine Cournoyer
Director · sold 16,000 at $46.94
$751k
27% of stake
Jul 1610b5-1 plan
Hannah Valantine
Director · sold 28,779 at avg $36.14
$1.04M
44% of stake
Jul 1610b5-1 plan
John Walter Hanna Jr
President and CEO · sold 118,000 at avg $37.78
$4.46M
15% of stake
Jun 26 – 2910b5-1 plan
John Walter Hanna Jr
President and CEO · sold 40,000 at avg $29.24
$1.17M
5.7% of stake
Jun 1510b5-1 plan
John Walter Hanna Jr
President and CEO · sold 17,683 at $24.03
$425k
2.7% of stake
Jun 1510b5-1 plan
Hannah Valantine
Director · sold 12,103 at $23.11
$280k
25% of stake
Jun 1110b5-1 plan
John Walter Hanna Jr
President and CEO · sold 21,998 at $24.02
$528k
3.3% of stake
Jun 410b5-1 plan
John Walter Hanna Jr
President and CEO · sold 4,835 at $24.00
$116k
0.7% of stake
May 14 – 15No plan
Arthur A Torres
Director · sold 10,570 at avg $20.31
$215k
21% of stake
May 510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 2,688 at $20.68
$56k
2.3% of stake
Apr 1610b5-1 plan
John Walter Hanna Jr
President and CEO · sold 10,282 at $21.12
$217k
1.5% of stake
Feb 310b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 4,441 at $20.56
$91k
3.4% of stake
Jan 21 – 2210b5-1 plan
John Walter Hanna Jr
President and CEO · sold 19,480 at avg $21.16
$412k
3.2% of stake
Jan 1510b5-1 plan
John Walter Hanna Jr
President and CEO · sold 10,156 at $21.05
$214k
1.6% of stake
Dec 4, 202510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 7,293 at avg $19.17
$140k
6.9% of stake
Nov 7, 202510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 2,688 at $15.52
$42k
2.5% of stake
Aug 5, 202510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 2,688 at $12.79
$34k
2.3% of stake
Jul 7, 202510b5-1 plan
Peter Maag
Director · sold 10,000 at $18.58
$186k
3.1% of stake
Jun 18, 202510b5-1 plan
Hannah Valantine
Director · sold 10,570 at $19.16
$203k
21% of stake
Jun 17, 202510b5-1 plan
Peter Maag
Director · sold 10,000 at $19.24
$192k
3.0% of stake
Jun 11, 2025No plan
William A Hagstrom
Director · sold 19,391 at $19.90
$386k
26% of stake
May 28, 2025No plan
William A Hagstrom
Director · sold 30,000 at $17.45
$524k
36% of stake
May 12, 2025No plan
Christine Cournoyer
Director · sold 29,136 at $15.96
$465k
44% of stake
May 6, 2025No plan
Christine Cournoyer
Director · sold 16,700 at $14.13
$236k
31% of stake
May 5, 202510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 2,688 at $14.70
$40k
2.2% of stake
Apr 30, 202510b5-1 plan
Peter Maag
Director · sold 13,281 at $17.23
$229k
4.0% of stake
Apr 7, 2025No plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 924 at $17.72
$16k
0.7% of stake
Apr 7, 2025No plan
Abhishek Jain
Chief Financial Officer · sold 265 at $17.72
$5k
<0.1% of stake
Mar 10, 2025No plan
George Bickerstaff
Director · sold 20,000 at $18.36
$367k
16% of stake
Feb 4, 202510b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 3,512 at $23.30
$82k
3.2% of stake
Dec 4, 202410b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 1,917 at $26.00
$50k
1.7% of stake
Nov 26, 202410b5-1 plan
Peter Maag
Director · sold 5,000 at $25.00
$125k
1.5% of stake
Nov 18, 2024 – Nov 25, 202410b5-1 plan
Jeffrey Adam Novack
Secretary and General Counsel · sold 6,757 at avg $22.17
$150k
5.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CDNA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

BLLNBillionToOne, Inc.

CSTLCastle Biosciences, Inc.

VCYTVeracyte Inc.

FLGTFulgent Genetics Inc.

Spot a number that looks wrong? Check it in CDNA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CDNA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.